{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:10:08Z","timestamp":1747645808126,"version":"3.40.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"DOI":"10.7759\/cureus.84380","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:37:21Z","timestamp":1747643841000},"source":"Crossref","is-referenced-by-count":0,"title":["Two Cases of Crovalimab-Induced Platelet Recovery in Bone Marrow Failure-Associated Paroxysmal Nocturnal Hemoglobinuria (PNH)"],"prefix":"10.7759","author":[{"given":"Takashi","family":"Onaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Imada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen P","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995, 333:1253-8. 10.1056\/NEJM199511093331904","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90250-t","article-title":"Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria","volume":"73","author":"Takeda J","year":"1993","unstructured":"Takeda J, Miyata T, Kawagoe K, et al.. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993, 73:703-11. 10.1016\/0092-8674(93)90250-t","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003812","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"137","author":"Brodsky RA","year":"2021","unstructured":"Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2021, 137:1304-9. 10.1182\/blood.2019003812","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker C","year":"2005","unstructured":"Parker C, Omine M, Richards S, et al.. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005, 106:3699-709.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2020.06.006","article-title":"Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria","volume":"43","author":"Can\u00e7ado RD","year":"2021","unstructured":"Can\u00e7ado RD, Ara\u00fajo AD, Sandes AF, et al.. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematol Transfus Cell Ther. 2021, 43:341-8. 10.1016\/j.htct.2020.06.006","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky RA","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E, et al.. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008, 111:1840-1847.","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.53.0684","article-title":"Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment","volume":"53","author":"Asano J","year":"2014","unstructured":"Asano J, Ueda R, Tanaka Y,  Shinzato I, Takafuta T. Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment. Intern Med. 2014, 53:125-8.","journal-title":"Intern Med"},{"key":"ref8","article-title":"Long-standing eculizumab treatment without anticoagulant therapy in high-risk thrombogenic paroxysmal nocturnal hemoglobinuria","volume":"23","author":"Al-Jafar HA","year":"2015","unstructured":"Al-Jafar HA, AlDallal SM, Askar HA, Aljeraiwi AM, Al-Alansari A. Long-standing eculizumab treatment without anticoagulant therapy in high-risk thrombogenic paroxysmal nocturnal hemoglobinuria. Hematol Rep. 2015, 23:5927.","journal-title":"Hematol Rep"},{"key":"ref9","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"23","author":"Kelly RJ","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, et al.. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011, 23:6786-92.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102528","article-title":"Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria","volume":"87","author":"Gurnari C","year":"2021","unstructured":"Gurnari C, Graham AC, Efanov A, et al.. Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria. Blood Cells Mol Dis. 2021, 87:102528.","journal-title":"Blood Cells Mol Dis"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.4030.4030","article-title":"Terminal complement inhibitor eculizumab improves complement-mediated platelet consumption and thrombocytopenia in patient with paroxysmal nocturnal hemoglobiuria (PNH)","volume":"114","author":"Socie G","year":"2009","unstructured":"Socie G, Muus P, Schrezenmeier H, et al.. Terminal complement inhibitor eculizumab improves complement-mediated platelet consumption and thrombocytopenia in patient with paroxysmal nocturnal hemoglobiuria (PNH). Blood. 2009, 114:4030.","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16394","article-title":"Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria","volume":"91","author":"Cosson V","year":"2025","unstructured":"Cosson V, Fu R, Kulasekararaj A, et al.. Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria. Br J Clin Pharmacol. 2025, 91:1479-90. 10.1111\/bcp.16394","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-125693","article-title":"Phase III clinical trial of Elizaria\u00ae and Soliris\u00ae in adult patients with paroxysmal nocturnal hemoglobinuria: results of comparative analysis of efficacy, safety, and pharmacological data","volume":"134","author":"Kulagin A","year":"2019","unstructured":"Kulagin A, Ptushkin V, Lukina E, Gapchenko E, Markova O, Zuev E, Kudlay D. Phase III clinical trial of Elizaria\u00ae and Soliris\u00ae in adult patients with paroxysmal nocturnal hemoglobinuria: results of comparative analysis of efficacy, safety, and pharmacological data. Blood. 2019, 134:3748.","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/368961-two-cases-of-crovalimab-induced-platelet-recovery-in-bone-marrow-failure-associated-paroxysmal-nocturnal-hemoglobinuria-pnh","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:37:23Z","timestamp":1747643843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/368961-two-cases-of-crovalimab-induced-platelet-recovery-in-bone-marrow-failure-associated-paroxysmal-nocturnal-hemoglobinuria-pnh"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.84380","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}